Codeine Drug Market Size, Share, Growth, and Industry Analysis, By Types (Single-ingredient Codeine, Multi-ingredient Medications Codeine), By Applications Covered (Narcotic Analgesic, Antitussive, Others), Regional Insights and Forecast to 2033

Detailed TOC of Global Codeine Drug Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Codeine Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications Codeine
1.3 Market by Application
1.3.1 Global Codeine Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Codeine Drug Market Perspective (2018-2033)
2.2 Codeine Drug Growth Trends by Region
2.2.1 Global Codeine Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Codeine Drug Historic Market Size by Region (2018-2025)
2.2.3 Codeine Drug Forecasted Market Size by Region (2024-2033)
2.3 Codeine Drug Market Dynamics
2.3.1 Codeine Drug Industry Trends
2.3.2 Codeine Drug Market Drivers
2.3.3 Codeine Drug Market Challenges
2.3.4 Codeine Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Codeine Drug Players by Revenue
3.1.1 Global Top Codeine Drug Players by Revenue (2018-2025)
3.1.2 Global Codeine Drug Revenue Market Share by Players (2018-2025)
3.2 Global Codeine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Codeine Drug Revenue
3.4 Global Codeine Drug Market Concentration Ratio
3.4.1 Global Codeine Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Codeine Drug Revenue in 2022
3.5 Codeine Drug Key Players Head office and Area Served
3.6 Key Players Codeine Drug Product Solution and Service
3.7 Date of Enter into Codeine Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Codeine Drug Breakdown Data by Type
4.1 Global Codeine Drug Historic Market Size by Type (2018-2025)
4.2 Global Codeine Drug Forecasted Market Size by Type (2024-2033)
5 Codeine Drug Breakdown Data by Application
5.1 Global Codeine Drug Historic Market Size by Application (2018-2025)
5.2 Global Codeine Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Codeine Drug Market Size (2018-2033)
6.2 North America Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Codeine Drug Market Size by Country (2018-2025)
6.4 North America Codeine Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Codeine Drug Market Size (2018-2033)
7.2 Europe Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Codeine Drug Market Size by Country (2018-2025)
7.4 Europe Codeine Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Codeine Drug Market Size (2018-2033)
8.2 Asia-Pacific Codeine Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Codeine Drug Market Size by Region (2018-2025)
8.4 Asia-Pacific Codeine Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Codeine Drug Market Size (2018-2033)
9.2 Latin America Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Codeine Drug Market Size by Country (2018-2025)
9.4 Latin America Codeine Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Codeine Drug Market Size (2018-2033)
10.2 Middle East & Africa Codeine Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Codeine Drug Market Size by Country (2018-2025)
10.4 Middle East & Africa Codeine Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Taiji
11.1.1 Taiji Company Detail
11.1.2 Taiji Business Overview
11.1.3 Taiji Codeine Drug Introduction
11.1.4 Taiji Revenue in Codeine Drug Business (2018-2025)
11.1.5 Taiji Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Detail
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Codeine Drug Introduction
11.2.4 Mallinckrodt Revenue in Codeine Drug Business (2018-2025)
11.2.5 Mallinckrodt Recent Development
11.3 TEVA
11.3.1 TEVA Company Detail
11.3.2 TEVA Business Overview
11.3.3 TEVA Codeine Drug Introduction
11.3.4 TEVA Revenue in Codeine Drug Business (2018-2025)
11.3.5 TEVA Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Codeine Drug Introduction
11.4.4 Johnson & Johnson Revenue in Codeine Drug Business (2018-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Medreich
11.5.1 Medreich Company Detail
11.5.2 Medreich Business Overview
11.5.3 Medreich Codeine Drug Introduction
11.5.4 Medreich Revenue in Codeine Drug Business (2018-2025)
11.5.5 Medreich Recent Development
11.6 Sanofi Aventis
11.6.1 Sanofi Aventis Company Detail
11.6.2 Sanofi Aventis Business Overview
11.6.3 Sanofi Aventis Codeine Drug Introduction
11.6.4 Sanofi Aventis Revenue in Codeine Drug Business (2018-2025)
11.6.5 Sanofi Aventis Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Codeine Drug Introduction
11.7.4 Cipla Revenue in Codeine Drug Business (2018-2025)
11.7.5 Cipla Recent Development
11.8 Hikma
11.8.1 Hikma Company Detail
11.8.2 Hikma Business Overview
11.8.3 Hikma Codeine Drug Introduction
11.8.4 Hikma Revenue in Codeine Drug Business (2018-2025)
11.8.5 Hikma Recent Development
11.9 Pharmaceutical Associates
11.9.1 Pharmaceutical Associates Company Detail
11.9.2 Pharmaceutical Associates Business Overview
11.9.3 Pharmaceutical Associates Codeine Drug Introduction
11.9.4 Pharmaceutical Associates Revenue in Codeine Drug Business (2018-2025)
11.9.5 Pharmaceutical Associates Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Codeine Drug Introduction
11.10.4 Novartis Revenue in Codeine Drug Business (2018-2025)
11.10.5 Novartis Recent Development
11.11 Apotex
11.11.1 Apotex Company Detail
11.11.2 Apotex Business Overview
11.11.3 Apotex Codeine Drug Introduction
11.11.4 Apotex Revenue in Codeine Drug Business (2018-2025)
11.11.5 Apotex Recent Development
11.12 Viatris
11.12.1 Viatris Company Detail
11.12.2 Viatris Business Overview
11.12.3 Viatris Codeine Drug Introduction
11.12.4 Viatris Revenue in Codeine Drug Business (2018-2025)
11.12.5 Viatris Recent Development
11.13 Aristo Pharma GmbH
11.13.1 Aristo Pharma GmbH Company Detail
11.13.2 Aristo Pharma GmbH Business Overview
11.13.3 Aristo Pharma GmbH Codeine Drug Introduction
11.13.4 Aristo Pharma GmbH Revenue in Codeine Drug Business (2018-2025)
11.13.5 Aristo Pharma GmbH Recent Development
11.14 Lannett Company
11.14.1 Lannett Company Company Detail
11.14.2 Lannett Company Business Overview
11.14.3 Lannett Company Codeine Drug Introduction
11.14.4 Lannett Company Revenue in Codeine Drug Business (2018-2025)
11.14.5 Lannett Company Recent Development
11.15 Laboratoire Riva
11.15.1 Laboratoire Riva Company Detail
11.15.2 Laboratoire Riva Business Overview
11.15.3 Laboratoire Riva Codeine Drug Introduction
11.15.4 Laboratoire Riva Revenue in Codeine Drug Business (2018-2025)
11.15.5 Laboratoire Riva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details